In Vivo Brain Reprogramming with Precise Spatial and Temporal Controls

GT Biosciences is developing ligand conjugated lipid nanoparticles for targeted brain gene editing, allowing controllable Cas9 and sgRNA activation via systematic injection.

Back to Award Directory